Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis.

George JD, Kim E, Spain R, Bourdette D, Salinthone S.

J Neuroimmunol. 2018 Feb 15;315:24-27. doi: 10.1016/j.jneuroim.2017.12.009. Epub 2017 Dec 19.

PMID:
29306401
2.

Coherence analysis of trunk and leg acceleration reveals altered postural sway strategy during standing in persons with multiple sclerosis.

Huisinga J, Mancini M, Veys C, Spain R, Horak F.

Hum Mov Sci. 2018 Apr;58:330-336. doi: 10.1016/j.humov.2017.12.009. Epub 2017 Dec 23.

PMID:
29277247
3.

Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.

Fiedler SE, Yadav V, Kerns AR, Tsang C, Markwardt S, Kim E, Spain R, Bourdette D, Salinthone S.

Mol Neurobiol. 2018 Jul;55(7):6037-6049. doi: 10.1007/s12035-017-0813-y. Epub 2017 Nov 15.

PMID:
29143287
4.

Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort.

Winges KM, Murchison CF, Bourdette DN, Spain RI.

Mult Scler. 2017 Nov 1:1352458517739136. doi: 10.1177/1352458517739136. [Epub ahead of print]

PMID:
29111873
5.

Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs.

Fiedler SE, George JD, Love HN, Kim E, Spain R, Bourdette D, Salinthone S.

J Syst Integr Neurosci. 2017 May;3(3). doi: 10.15761/JSIN.1000166. Epub 2017 Jun 17.

6.

Optical coherence tomography angiography enhances the detection of optic nerve damage in multiple sclerosis.

Spain RI, Liu L, Zhang X, Jia Y, Tan O, Bourdette D, Huang D.

Br J Ophthalmol. 2018 Apr;102(4):520-524. doi: 10.1136/bjophthalmol-2017-310477. Epub 2017 Aug 16.

PMID:
28814415
7.

Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS.

Bittner F, Murchison C, Koop D, Bourdette D, Spain R.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 28;4(5):e380. doi: 10.1212/NXI.0000000000000380. eCollection 2017 Sep. No abstract available.

8.

Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.

Spain R, Powers K, Murchison C, Heriza E, Winges K, Yadav V, Cameron M, Kim E, Horak F, Simon J, Bourdette D.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 28;4(5):e374. doi: 10.1212/NXI.0000000000000374. eCollection 2017 Sep.

9.

Nicolau syndrome and localized panniculitis: a report of dual diagnoses with an emphasis on morphea profunda-like changes following injection with glatiramer acetate.

Mott SE, Peña ZG, Spain RI, White KP, Ehst BD.

J Cutan Pathol. 2016 Nov;43(11):1056-1061. doi: 10.1111/cup.12791. Epub 2016 Sep 8.

PMID:
27516414
10.

Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.

Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, Riddehough A, Li DK, McDougall J, Lovera J, Murchison C, Bourdette D.

Mult Scler Relat Disord. 2016 Sep;9:80-90. doi: 10.1016/j.msard.2016.07.001. Epub 2016 Jul 6.

11.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

12.

Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.

Nourbakhsh B, Azevedo C, Maghzi AH, Spain R, Pelletier D, Waubant E.

J Neurol Sci. 2016 Jul 15;366:229-233. doi: 10.1016/j.jns.2016.04.054. Epub 2016 May 6.

PMID:
27288812
13.

Longitudinal associations between MRI and cognitive changes in very early MS.

Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C, Lazar A, Pelletier D, Waubant E.

Mult Scler Relat Disord. 2016 Jan;5:47-52. doi: 10.1016/j.msard.2015.10.010. Epub 2015 Oct 26.

PMID:
26856943
14.

Longitudinal associations between brain structural changes and fatigue in early MS.

Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E.

Mult Scler Relat Disord. 2016 Jan;5:29-33. doi: 10.1016/j.msard.2015.10.006. Epub 2015 Oct 21.

PMID:
26856940
15.

Characterization of Compensatory Stepping in People With Multiple Sclerosis.

Peterson DS, Huisinga JM, Spain RI, Horak FB.

Arch Phys Med Rehabil. 2016 Apr;97(4):513-521. doi: 10.1016/j.apmr.2015.10.103. Epub 2015 Nov 18.

16.

Retinal axonal loss in very early stages of multiple sclerosis.

Maghzi AH, Graves J, Revirajan N, Spain R, Liu S, McCulloch CE, Pelletier D, Green AJ, Waubant E.

Eur J Neurol. 2015 Jul;22(7):1138-41. doi: 10.1111/ene.12722. Epub 2015 Apr 29.

PMID:
25929276
17.

Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.

Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E.

Mult Scler Relat Disord. 2014 Nov;3(6):720-7. doi: 10.1016/j.msard.2014.07.003. Epub 2014 Jul 23.

PMID:
25891551
18.

A randomized controlled phase II trial of riluzole in early multiple sclerosis.

Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D.

Ann Clin Transl Neurol. 2014 May;1(5):340-7. doi: 10.1002/acn3.60. Epub 2014 Apr 14.

19.

Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.

Wang X, Jia Y, Spain R, Potsaid B, Liu JJ, Baumann B, Hornegger J, Fujimoto JG, Wu Q, Huang D.

Br J Ophthalmol. 2014 Oct;98(10):1368-73. doi: 10.1136/bjophthalmol-2013-304547. Epub 2014 May 15.

20.

Postural response latencies are related to balance control during standing and walking in patients with multiple sclerosis.

Huisinga JM, St George RJ, Spain R, Overs S, Horak FB.

Arch Phys Med Rehabil. 2014 Jul;95(7):1390-7. doi: 10.1016/j.apmr.2014.01.004. Epub 2014 Jan 18.

21.

Body-worn sensors capture variability, but not decline, of gait and balance measures in multiple sclerosis over 18 months.

Spain RI, Mancini M, Horak FB, Bourdette D.

Gait Posture. 2014 Mar;39(3):958-64. doi: 10.1016/j.gaitpost.2013.12.010. Epub 2013 Dec 21.

22.

Mind-body medicine for multiple sclerosis: a systematic review.

Senders A, Wahbeh H, Spain R, Shinto L.

Autoimmune Dis. 2012;2012:567324. doi: 10.1155/2012/567324. Epub 2012 Nov 22.

23.

1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.

Cameron M, Wagner J, Zackowski K, Spain R.

Mult Scler Int. 2012;2012:720206. doi: 10.1155/2012/720206. Epub 2012 Jun 17.

24.

Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed.

Spain RI, St George RJ, Salarian A, Mancini M, Wagner JM, Horak FB, Bourdette D.

Gait Posture. 2012 Apr;35(4):573-8. doi: 10.1016/j.gaitpost.2011.11.026. Epub 2012 Jan 25.

25.

Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.

Solomon AJ, Spain RI, Kruer MC, Bourdette D.

Mult Scler. 2011 Dec;17(12):1472-87. doi: 10.1177/1352458511412996. Epub 2011 Aug 3. Review.

PMID:
21816758
26.

The radiologically isolated syndrome: look (again) before you treat.

Spain R, Bourdette D.

Curr Neurol Neurosci Rep. 2011 Oct;11(5):498-506. doi: 10.1007/s11910-011-0213-z. Review.

PMID:
21748263
27.

Clinicians' experiences of participating in an action research study.

Li PL, Bashford L, Schwager G, Spain R, Ryan H, Oakman M, Firth J, Lockyer M, Harper D, Higgins I.

Contemp Nurse. 2010 Jun;35(2):147-56. doi: 10.5172/conu.2010.35.2.147.

PMID:
20950196
28.

Recent developments in multiple sclerosis therapeutics.

Spain RI, Cameron MH, Bourdette D.

BMC Med. 2009 Dec 7;7:74. doi: 10.1186/1741-7015-7-74.

29.
30.

When metals compete: a case of copper-deficiency myeloneuropathy and anemia.

Spain RI, Leist TP, De Sousa EA.

Nat Clin Pract Neurol. 2009 Feb;5(2):106-11. doi: 10.1038/ncpneuro1008.

PMID:
19194390
31.
32.

The case for mitomycin in non-small cell lung cancer.

Spain RC.

Oncology. 1993 Apr;50 Suppl 1:35-50. Review.

PMID:
8387177
33.

Respiratory emergencies in patients with cancer.

Spain RC, Whittlesey D.

Semin Oncol. 1989 Dec;16(6):471-89. Review. No abstract available.

PMID:
2688108
35.

Myocardial Na-K adenosine triphosphatase activity during reversal of ouabain toxicity with diphenylhydantoin.

Spain RC, Chidsey CA.

J Pharmacol Exp Ther. 1971 Dec;179(3):594-8. No abstract available.

PMID:
4257806
36.

Rehabilitative nursing.

Spain RW.

Nurs Clin North Am. 1966 Sep;1(3):355-63. No abstract available.

PMID:
4223087
37.

REHABILITATION NURSING FOR THE LONG-TERM PATIENT.

SPAIN RW.

Rehabil Lit. 1964 May;25:130-8. Review. No abstract available.

PMID:
14144242
38.

The long-term patient: a new challenge to nursing.

FOX V, SPAIN RW.

Nurs Outlook. 1956 Oct;4(10):559-61. No abstract available.

PMID:
13369926
39.

Leptospirosis due to Leptospira grippotyphosa; first report of occurrence in United States.

SPAIN RS, HOWARD GT.

J Am Med Assoc. 1952 Nov 8;150(10):1010-2. No abstract available.

PMID:
12990341

Supplemental Content

Support Center